CompaniesNoscendo

Noscendo

active
Duisburg, Germany
Founded 2018
Website
About

Pathogen ID via NGS

Areas of Focus

Categories

Diagnostics
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

600

By Phase

NA: 1

By Status

RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
Today
NCT06075888
NCT05815628
Hover over trial bars to see details

Recent Trials

NCT05815628Collaborator
Next-Generation-Sequencing Approach to Neutropenic Sepsis
N/ARecruiting
400 participants
Started: Jun 5, 2024 · Completed: Nov 1, 2026
NCT06075888Collaborator
Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients
NARecruiting
200 participants
Started: Jan 12, 2024 · Completed: Jan 12, 2025
Locations (1)
Headquarters
Duisburg, Germany
Map

Loading map...